Actively Recruiting

Phase Not Applicable
Age: 50Years - 74Years
All Genders
NCT06636058

Digital InteGrated Behavioral TreatmeNt for Comorbid ObesITy and DeprEssion Among Racial and Ethnic Adults Age 50 and Older

Led by University of Illinois at Chicago · Updated on 2025-02-27

440

Participants Needed

2

Research Sites

194 weeks

Total Duration

On this page

Sponsors

U

University of Illinois at Chicago

Lead Sponsor

W

Washington University School of Medicine

Collaborating Sponsor

AI-Summary

What this Trial Is About

The goal of this randomized clinical trial is to test the efficacy of a fully digital intervention, combining the Lumen problem-solving therapy virtual coach for depression management with the Diabetes Prevention Program video-based program for weight loss, among racial and ethnic minorities with comorbid depression and obesity. The study aims include: * Determine the efficacy of the vCare intervention at 6 months. Primary outcomes are weight and depression symptom checklist 20-item (SCL-20) score. * Identify predictors of treatment success, defined by achieving clinically significant weight loss (5%) and depression outcomes (50% decline or SCL-20\<0.5), at 6 and 12 months. * Characterize participant experiences and perceptions of the vCare intervention. Eligible participants will be randomized to the early-intervention arm who will receive active treatment for 6 months, followed by maintenance for another 6 months, or the later-intervention arm who will be waitlisted for 6 months and then receive active treatment in the second 6 months.

CONDITIONS

Official Title

Digital InteGrated Behavioral TreatmeNt for Comorbid ObesITy and DeprEssion Among Racial and Ethnic Adults Age 50 and Older

Who Can Participate

Age: 50Years - 74Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 50-74 years (inclusive)
  • Confirmed body mass index (BMI) between 27.0 and less than 45.0 based on weight and height measured by study staff
  • Confirmed weight 396 lbs or less
  • Patient Health Questionnaire-9 (PHQ-9) score between 10 and less than 20, indicating moderate to moderately severe depression
  • Self-identified race and ethnicity other than non-Hispanic White
  • Willing and able to accept randomization and provide informed e-consent and HIPAA authorization
Not Eligible

You will not qualify if you...

  • Unable to speak, read, or understand English sufficiently for informed consent
  • No reliable Wi-Fi Internet access at home
  • Pre-existing type 1 or type 2 diabetes, coronary heart disease, heart failure, stroke, recent cancer diagnosis or treatment (except non-melanoma skin cancer), end-stage organ failure, living in long-term care, or life expectancy less than 24 months
  • Weight change greater than 15 lbs in the past 3 months
  • Current active weight loss treatment or participation in conflicting behavioral, medical, or surgical studies
  • Regular use of prescription medications that affect appetite or weight
  • Planned or prior bariatric surgery within the past 2 years
  • Positive screen for bulimia nervosa
  • Unable to pass physical activity readiness screening or lack physician clearance
  • Active suicidal thoughts with plan or intent
  • Bipolar or psychotic disorder or current treatment for psychiatric conditions
  • Cognitive impairment based on screening
  • Active alcohol or substance use disorder
  • Current or planned pregnancy or breastfeeding less than 6 months postpartum
  • Family member of enrolled participant or study team member
  • Investigator discretion for safety or protocol adherence reasons

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

Department of Medicine, Vitoux Program on Aging and Prevention

Chicago, Illinois, United States, 60608

Actively Recruiting

2

Washington University School of Medicine in St Louis

St Louis, Missouri, United States, 63110

Not Yet Recruiting

Loading map...

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here